Shallaki (Boswellia serrata)

Shallaki (Boswellia serrata) is an Ayurvedic herb containing boswellic acids that inhibit 5-lipoxygenase, reducing inflammation in joints and digestive tract. The primary bioactive compounds are 11-keto-β-boswellic acid and acetyl-11-keto-β-boswellic acid.

Origin & History

Shallaki, also known as Indian frankincense, is derived from the resin of the Boswellia serrata tree, native to India. The resin is collected and processed into various forms for medicinal use.

Historical & Cultural Context

Shallaki has been used for centuries in Ayurvedic medicine to treat inflammatory conditions and support joint health. It is also used in religious rituals and traditional ceremonies.

Health Benefits

- Reduces inflammation: Shallaki contains boswellic acids that inhibit inflammatory enzymes, easing joint pain. - Supports joint health: It enhances cartilage production, improving joint flexibility and reducing stiffness. - Promotes gut health: By reducing gut inflammation, it aids in digestion and nutrient absorption. - Enhances respiratory function: Its anti-inflammatory properties ease asthma symptoms, improving lung function. - Boosts immunity: Shallaki enhances immune response by increasing white blood cell activity, protecting against infections. - Improves skin health: Its antioxidant properties combat free radicals, leading to healthier, more radiant skin. - Supports cardiovascular health: By reducing cholesterol levels, it promotes heart health and reduces the risk of heart disease.

How It Works

Boswellic acids in Shallaki selectively inhibit 5-lipoxygenase enzyme, blocking leukotriene synthesis and reducing inflammatory cascades. The compound 11-keto-β-boswellic acid specifically targets microsomal prostaglandin E synthase-1 (mPGES-1). This dual inhibition of inflammatory pathways reduces joint inflammation and supports cartilage matrix preservation.

Scientific Research

Studies on Shallaki have shown promising results in reducing inflammation and pain associated with arthritis, supported by randomized controlled trials and meta-analyses.

Clinical Summary

Multiple randomized controlled trials with 60-120 participants show Shallaki extract (300-400mg daily) reduces joint pain scores by 40-65% over 8-16 weeks. A 2019 systematic review found moderate evidence for osteoarthritis symptom improvement compared to placebo. Studies using standardized extracts containing 30-65% boswellic acids demonstrate the strongest anti-inflammatory effects. However, most trials are small-scale and require larger, longer-duration studies for definitive conclusions.

Nutritional Profile

Shallaki (Boswellia serrata) is not consumed as a food for macronutrient value; it is used primarily as a resinous gum extract valued for its bioactive compounds. Key bioactive constituents include boswellic acids (typically 30–65% of standardized extracts), with the most pharmacologically significant being acetyl-11-keto-β-boswellic acid (AKBA, approximately 2–5% of crude resin, up to 30% in high-potency standardized extracts), 11-keto-β-boswellic acid (KBA, ~3–5%), β-boswellic acid (~15–25%), and acetyl-β-boswellic acid (~5–10%). The resin also contains α-boswellic acid and its acetyl derivative. Other bioactive compounds include incensole and incensole acetate (diterpenes, ~1–2%), as well as essential oils (5–9% of the oleo-gum-resin) composed of α-thujene, α-pinene, myrcene, limonene, and p-cymene. The gum portion (~20–30% of the raw oleo-gum-resin) contains arabinose, galactose, and xylose-based polysaccharides, providing minor soluble fiber. Mineral content is negligible in typical supplemental doses but trace amounts of calcium, magnesium, and potassium may be present in the crude gum. Protein and fat content are minimal and nutritionally insignificant at standard dosages (300–1200 mg/day of extract). Bioavailability of boswellic acids, particularly AKBA, is inherently low due to poor aqueous solubility and significant first-pass metabolism; however, co-administration with lipids or use of phospholipid-complexed (phytosomal) formulations such as Boswellia Phytosome® (Casperome®) can increase plasma bioavailability of AKBA by approximately 5–10 fold. Lecithin-based delivery and piperine co-supplementation have also been shown to enhance absorption. Peak plasma concentrations of boswellic acids are typically reached 3–5 hours post-ingestion, with a half-life of approximately 6 hours for AKBA.

Preparation & Dosage

Shallaki is often consumed in capsule or tablet form, with typical doses ranging from 300-500 mg two to three times daily. Consult a healthcare provider before use.

Synergy & Pairings

Turmeric, Ginger, Ashwagandha

Safety & Interactions

Shallaki is generally well-tolerated with mild gastrointestinal upset reported in 5-10% of users. It may enhance anticoagulant effects of warfarin and increase bleeding risk when combined with NSAIDs. Individuals with autoimmune conditions should consult healthcare providers as it may stimulate immune activity. Safety during pregnancy and breastfeeding is not established, so use should be avoided during these periods.